Berberine Bioavailability, Capsule Burden, and Routine Fit: What Brands Should Evaluate
A B2B formulation article on berberine bioavailability, active loading, daily serving design, GI tolerance, and routine-fit positioning.
A B2B formulation article on berberine bioavailability, active loading, daily serving design, GI tolerance, and routine-fit positioning.
A B2B technical guide to Berberine Pro-Micelle Fiber 50, dry-powder self-emulsifying design, 50% active loading, and 1 g/day routine fit.
A guide to using Magnesium Acetyl Taurate 30-day tolerability and user-experience pilot endpoints for B2B formulation review without disease claims.
A B2B evaluation guide for Magnesium Acetyl Taurate, acetyl-taurate identity, calm-focus positioning, and evidence package review.
A claim-boundary guide for positioning Vital Porphyrin and methyl-burden-aware NAD+ support without overclaiming safety or disease benefits.
A B2B technical note on Vital Porphyrin, endogenous NAD+ renewal positioning, low-dose formulation space, and methyl-burden-aware language.
A formulation guide for using NAD Pro in premium longevity products with dose logic, delivery-system language, evidence review, and claim discipline.
A B2B guide to evaluating NAD+ ingredient platforms through human biomarker response, analytical method support, formulation fit, and claim boundaries.